期刊文献+

双稳健半参模型法评价CAF和TAC化疗方案治疗乳腺癌疗效的回顾性分析 被引量:3

Retrospective Analysis on the Efficacy of CAF and TAC Chemotherapy in the Treatment of Breast Cancer with Double-robust Semiparametric Model Method
下载PDF
导出
摘要 目的探索TAC化疗方案和CAF化疗方案治疗乳腺癌的真实疗效。方法采用回顾性队列研究的方法选择乳腺癌患者800例,探索不同的化疗方案对乳腺癌患者的生存率的影响。结果 PS匹配后经过log-rank检验两组生存曲线之间差别有统计学意义(P<0.05),得出TAC化疗方案治疗乳腺癌的效果优于CAF化疗方案。PS匹配前利用Cox回归模型和logistic回归模型,分别采用PS回归调整法、PS逆概率处理加权法(IPTW)、PS标化死亡比加权法(SMRW)和双稳健半参模型法(PS回归调整与加权法的结合,DRW)进行两种化疗方案的生存分析,加权之后基线协变量得到均衡,并经过调整的log-rank检验两组生存曲线之间差别均有统计学意义(P<0.05),且结果均显示TAC化疗方案治疗乳腺癌的效果优于CAF化疗方案。通过对不同模型之间的比较,利用DRIPTW模型和DRSMRW模型得出的处理效应的偏倚显著减小,且减小偏倚的效果优于与之相对的IPTW和SMRW法,同时也优于匹配法和回归调整法,其中DRSMRW模型法最优,相对偏倚为0.037。结论在回顾性队列研究中,TAC化疗方案治疗乳腺癌的效果优于CAF化疗方案,为乳腺癌患者指定了最佳的治疗方案。 Objective This study was aimed to explore the real efficacy of TAC and CAF chemotherapy in the treatment of breast cancer.Methods A retrospective cohort study was adopted to investigate 800 breast cancer patients,then explore the impact of different chemotherapy regimens on the survival rate of patients with breast cancer.Results The age,marital status and tumor nature of the two groups of breast cancer patients matched by PS matching were not balanced before matching,and after the matching,the survival curves of the two groups had significant difference after Log-rank test(P<0.05).Concluded that TAC chemotherapy regimen in the treatment of breast cancer better than the CAF chemotherapy.Before matching,Cox regression model and logistic regression model were used.And PS integrative regression adjustment,PS inverse probability weighting method(IPTW),PS standardized mortality weighting method(SMRW) were applied to the analysis on the two chemotherapy regimens.After adjusted Log-rank test between the two survival curves were statistically significant(P<0.05),and the results showed that TAC Chemotherapy regimen for breast cancer is superior to CAF regimen.By comparing the different models,the bias of the treatment effect obtained by the SMRW model and the DRSMRW model was significantly reduced,and the effect of reducing the bias was superior to the corresponding IPTW and SMRW methods and also better than the matching method and regression adjustment method.The DRSMRW model method was the best,the relative bias was 0.037.Conclusion In a retrospective cohort study,the effect of TAC chemotherapy regimen on breast cancerwas superior to that of CAF chemotherapy regimen.Designated the best treatment for breast cancer patients.
作者 田野 马洁 黄璐 杜泽玉 吕军城 石福艳 孟维静 王素珍 潘庆忠 Tian Ye;Ma Jie;Huang Lu(Weifang Medical University(261053),Weifang)
机构地区 潍坊医学院
出处 《中国卫生统计》 CSCD 北大核心 2019年第1期57-61,共5页 Chinese Journal of Health Statistics
基金 国家自然科学基金资助(81473071) 山东省自然科学基金资助(ZR2013HM045)
关键词 双稳健半参模型 乳腺癌 CAF TAC 化疗方案 倾向性评分 疗效评价 Breast cancer CAF TAC Chemotherapy Propensity score Double-robust model Efficacy evaluation
  • 相关文献

参考文献5

二级参考文献42

  • 1孟洁,宁连胜.179例35岁以下女性乳腺癌生存分析[J].中华普通外科杂志,2006,21(6):450-451. 被引量:7
  • 2Robins JM,Heman MA,Brumback B.Marginal structural models and causal inference in epidemiology[J].Epidemiology,2000,11:550-560.
  • 3Heman MA,Brumback B,Robins JM.Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men[J].Epidemiology,2000,11:561-570.
  • 4Sato T,Matsuyama Y.Marginal structural models as a tool for standardization[J].Epidemiology,2003,14:680-686.
  • 5Sturmer T,Rothman KJ,Glynn RJ.Insights into different results from different causal contrasts in the presence of effect-measure modification[J].Pharmacoepidemiol Drug Saf,2006,15:698-709.
  • 6Kurth T,Walker AM,Glynn RJ,et al.Results of multivariable logistic regression,propensity matching,propensity adjustment,and propensity-based weighting under conditions of nonuniform effect[J].Am J Epidemiol,2006,163:262 270.
  • 7D'Agostino RB Jr.Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group[J].Stat Med,1998,17:2265-2281.
  • 8Jemal A,Sigel R,Ward E. Cancer statistics,2006[J].{H}CA-A Cancer Journal for Clinicians,2006.106-130.
  • 9LaPensee EW,Ben-Jonathan N. Novel roles of prolactin and estrogens in breast cancer:resistance to chemotherapy[J].{H}ENDOCRINE-RELATED CANCER,2010.91-107.
  • 10Kocic B,Filipovic S,Vrbic V. Breast cancer in women under 40 years of age[J].J BUON,2011.635-539.

共引文献42

同被引文献26

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部